Interim positron emission tomography scan associated with international prognostic index and germinal center B cell-like signature as prognostic index in diffuse large B-cell lymphoma

References

• Lenz G, Staudt LM. Aggressive lymphomas. N Engl J Med 2010;362:1417–1429.
   PubMed Web of Science ®Google Scholar
• Lenz G, Wright GW, Emre NC, . Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci USA 2008;105:13520–13525.
   PubMed Web of Science ®Google Scholar
• Jardin F, Jais JP, Molina TJ, . Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study. Blood 2010;116:1092–1104.
   PubMed Web of Science ®Google Scholar
• Meyer PN, Fu K, Greiner TC, . Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. J Clin Oncol 2010;29:200–207.
   PubMed Web of Science ®Google Scholar
• Seam P, Juweid ME, Cheson BD. The role of FDG-PET scans in patients with lymphoma. Blood 2007;110:3507–3516.
   PubMed Web of Science ®Google Scholar
• Haioun C, Itti E, Rahmouni A, . [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Blood 2005;106:1376–1381.
   PubMed Web of Science ®Google Scholar
• Itti E, Lin C, Dupuis J, . Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy. J Nucl Med 2009;50:527–533.
   PubMed Web of Science ®Google Scholar
• Lin C, Itti E, Haioun C, . Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis. J Nucl Med 2007;48:1626–1632.
   PubMed Web of Science ®Google Scholar
• Koga H, Matsuo Y, Sasaki M, . Differential FDG accumulation associated with GLUT-1 expression in a patient with lymphoma. Ann Nucl Med 2003;17:327–331.
   PubMed Web of Science ®Google Scholar
• Shim HK, Lee WW, Park SY, . Relationship between FDG uptake and expressions of glucose transporter type 1, type 3, and hexokinase-II in Reed-Sternberg cells of Hodgkin lymphoma. Oncol Res 2009;17:331–337.
   PubMed Web of Science ®Google Scholar
• Shim HK, Lee WW, Park SY, . Expressions of glucose transporter types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas. Nucl Med Biol 2009;36:191–197.
   PubMed Web of Science ®Google Scholar
• Kaira K, Oriuchi N, Shimizu K, . Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer. Cancer Sci 2009;100:753–758.
   PubMed Web of Science ®Google Scholar
• Ma WW, Jacene H, Song D, . [18F]fluorodeoxyglucose positron emission tomography correlates with Akt pathway activity but is not predictive of clinical outcome during mTOR inhibitor therapy. J Clin Oncol 2009;27:2697–2704.
   PubMed Web of Science ®Google Scholar
• Watanabe R, Tomita N, Takeuchi K, . SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma. Leuk Lymphoma 2010;51:279–283.
   PubMed Web of Science ®Google Scholar
• Hans CP, Weisenburger DD, Greiner TC, . Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103:275–282.
   PubMed Web of Science ®Google Scholar
• Wright G, Tan B, Rosenwald A, . A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci USA 2003;100:9991–9996.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Pfistner B, Juweid ME, . Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25:579–586.
   PubMed Web of Science ®Google Scholar
• R Development Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2010. Available from: http://www.R-project.org/
   Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser 1995;57:289–300.
   Google Scholar
• Tohma T, Okazumi S, Makino H, . Relationship between glucose transporter, hexokinase and FDG-PET in esophageal cancer. Hepatogastroenterology 2005;52:486–490.
   PubMed Web of Science ®Google Scholar
• de Geus-Oei LF, van Krieken JH, Aliredjo RP, . Biological correlates of FDG uptake in non-small cell lung cancer. Lung Cancer 2007;55:79–87.
   PubMed Web of Science ®Google Scholar
• Karam M, Ata A, Irish K, . FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome. Nucl Med Commun 2009;30:770–778.
   PubMed Web of Science ®Google Scholar
• Le Dortz L, De Guibert S, Bayat S, . Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma. Eur J Nucl Med Mol Imaging 2010;37:2307–2314.
   PubMed Web of Science ®Google Scholar
• Phan J, Mazloom A, Jeffrey Medeiros L, . Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy. J Clin Oncol 2010;28:4170–4176.
   PubMedGoogle Scholar
• Chihara D, Oki Y, Onoda H, . High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma. Int J Hematol 2011;93:502–508.
   PubMed Web of Science ®Google Scholar
• Cheson BD. Role of functional imaging in the management of lymphoma. J Clin Oncol 2011;29:1844–1854.
   PubMed Web of Science ®Google Scholar
• Casasnovas RO, Meignan M, Berriolo-Riedinger A, . SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma. Blood 2011 Apr 25. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Ruminy P, Etancelin P, Couronne L, . The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma. Leukemia 2011;25:681–688.
   PubMed Web of Science ®Google Scholar
• Barrans SL, Worrillow L, Care M, . Gene expression profiling using the Illumina “DASL” platform on RNA extracted from formalin fixed paraffin embedded (FFPE) tissue identifies distinct prognostic groups in CHOP-R treated DLBCL. Blood 2010;116(Suppl. 1): Abstract 2485.
   Google Scholar
• Gutierrez-Garcia G, Cardesa-Salzmann T, Climent F, . Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Blood 2011;117:4836–4843.
   PubMed Web of Science ®Google Scholar
• Meyer PN, Fu K, Greiner TC, . Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. J Clin Oncol 2011;29:200–207.
   PubMed Web of Science ®Google Scholar